BMJ

1. SINGH M, Pati S
   Extrapulmonary tuberculosis is understudied in preventive vaccine trials.
   BMJ. 2026;393:s835.
   

   >> Share

   
   

   
   Clin Infect Dis

2. ROUSSY JF, Dennis P, Gupta AK, Wallace G, et al
   Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults >/= 50 Years of Age.
   Clin Infect Dis. 2026 Apr 29:ciag208. doi: 10.1093.
   

   >> Share

   
   
3. FOSTER CB
   When Polymerase Chain Reaction Positivity Is Not Disease: Implications for Clostridioides difficile Vaccine Trial Endpoints.
   Clin Infect Dis. 2026 Apr 29:ciag238. doi: 10.1093.
   

   >> Share

   
   
4. COSGROVE CA, Avanesov A, Rust D, Osibajo S, et al
   A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults.
   Clin Infect Dis. 2026 Apr 25:ciag278. doi: 10.1093.
   

   >> Share

   
   
5. BRAGASON HT, Rognvaldsson KG, Hernandez UB, Erlendsdottir H, et al
   Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study.
   Clin Infect Dis. 2026;82:e652-e661.
   

   >> Share

   
   
6. PANAGIOTOPOULOS AP, Anastassopoulou C, Tsakris A, Ioannidis JPA, et al
   Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs.
   Clin Infect Dis. 2025 Nov 25:ciaf648. doi: 10.1093.
   

   >> Share

   
   
7. FAFI I, Levy C, Birgy A, Bechet S, et al
   Impact of Respiratory Syncytial Virus Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis.
   Clin Infect Dis. 2026;82:658-664.
   

   >> Share

   
   

   
   J Gen Virol

8. CHIANG HL, Lin HT, Chen WY, Liang KH, et al
   Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants.
   J Gen Virol. 2026;107:002251.
   

   >> Share

   
   

   
   J Immunol

9. JONES E, Beekmayer-Dhillon A, Day N, Dinesh T, et al
   Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.
   J Immunol. 2026;215:vkag044.
   

   >> Share

   
   

   
   J Infect

10. KIM HK, Jo S, Min KD, Cho SI, et al
    Effectiveness of bivalent COVID-19 vaccines against SARS-CoV-2 reinfection in Patients With Cancer: Evidence From a Nationwide Target Trial Emulation.
    J Infect. 2026 Apr 28:106753. doi: 10.1016/j.jinf.2026.106753.
    

    >> Share

    
    

    
    J Infect Dis

11. PASCARD J, Desgraupes S, Chiche A, Jeannin P, et al
    In Vivo Risk Assessment of Yellow Fever Virus Transmission Through Breastfeeding, and Mechanistic Insights.
    J Infect Dis. 2026;233:e1056-e1068.
    

    >> Share

    
    
12. KLAASSEN F, Swartwood NA, Chitwood MH, Lopes R, et al
    National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis.
    J Infect Dis. 2026;233:714-724.
    

    >> Share

    
    

    
    J Virol

13. LIU K, Liu Z, Yan X, Yang Z, et al
    A single residue in the VP3 capsid protein governs virulence and informs live-attenuated vaccine design for coxsackievirus A6.
    J Virol. 2026 Apr 27:e0014926. doi: 10.1128/jvi.00149.
    

    >> Share

    
    
14. HENG W, Zhou Z, Lin W, Zhang X, et al
    A novel replication-deficient feline herpesvirus type 1 vector-based vaccine provides strong immune protection in cats.
    J Virol. 2026 Apr 27:e0218825. doi: 10.1128/jvi.02188.
    

    >> Share

    
    

    
    JAMA

15. ANDERER S
    HPV Vaccine Lowers Related Cancer Risk in Younger Males.
    JAMA. 2026 May 1. doi: 10.1001/jama.2026.2127.
    

    >> Share

    
    
16. ANDERER S
    Most US Health Care Workers Vaccinated for Flu, Less Than Half for COVID-19.
    JAMA. 2026 May 1. doi: 10.1001/jama.2026.2126.
    

    >> Share

    
    

    
    Lancet

17. DU X, Anderson CS
    Off-target benefits of influenza vaccination in cardiovascular disease - Authors' reply.
    Lancet. 2026;407:1600.
    

    >> Share

    
    
18. FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
    Off-target benefits of influenza vaccination in cardiovascular disease.
    Lancet. 2026;407:1599-1600.
    

    >> Share

    
    
19. MCLELLAN F
    Amadou Sall: virologist committed to vaccine equity.
    Lancet. 2026;407:1590.
    

    >> Share

    
    
20. NELSON NP, Ward JW
    Hepatitis A prevention in the USA depends on routine universal childhood vaccination.
    Lancet. 2026 Apr 22:S0140-6736(26)00510-6. doi: 10.1016/S0140-6736(26)00510.
    

    >> Share

    
    

    
    Pediatrics

21. ENGSTROM EE, Kaplan SL, Barson WJ, Lin PL, et al
    Pneumococcal Pneumonia in Hospitalized Children: 2017-2023.
    Pediatrics. 2026;157:e2025073196.
    

    >> Share

    
    

    
    PLoS Med

22. WILDER-SMITH A
    Optimizing dengue vaccination strategies.
    PLoS Med. 2026;23:e1005068.
    

    >> Share

    
    

    
    PLoS One

23. KO CC, Wu JY, Hung KC, Liao SW, et al
    The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation/flutter after COVID-19 infection: A retrospective cohort study.
    PLoS One. 2026;21:e0348133.
    

    >> Share

    
    
24. BASHIR K, Ouedraogo MO, Dharma C, Sobers M, et al
    Strengthening access to and confidence in COVID-19 vaccines among equity-deserving populations across Canada: An exploratory qualitative study.
    PLoS One. 2026;21:e0301953.
    

    >> Share

    
    
25. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
    Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey.
    PLoS One. 2026;21:e0348076.
    

    >> Share

    
    
26. LI Y, Chen T, Zhao Y, Ke W, et al
    Auditing the impact of social media's policy shift on anti-vaccine discourse: A large language model-driven empirical study.
    PLoS One. 2026;21:e0346568.
    

    >> Share

    
    
27. MUNNE-BARELLAS B, Garcia-Egea A, Giner-Soriano M, Vedia-Urgell C, et al
    Healthcare professionals' perspectives on medicine prescribing, vaccination, and alternative therapies in pregnancy and breastfeeding: A qualitative study from Catalonia, Spain.
    PLoS One. 2026;21:e0345521.
    

    >> Share

    
    
28. SHAHMIRZALOU P, Ebrahimpour Sadagheyani H
    Epidemiology and trends of animal bites in Khoy County, Northwest Iran: A retrospective study (2021-2024).
    PLoS One. 2026;21:e0348132.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

29. HABIB R, Solieva SO, Lin ZJ, Ghosh S, et al
    Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccination.
    Proc Natl Acad Sci U S A. 2026;123:e2532810123.
    

    >> Share

    
    
30. ZHANG Y, Wang C, Zheng Y, Chen F, et al
    An Ad5-vectored platform generating self-assembling VLPs elicits potent mucosal immunity against influenza A virus and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2026;123:e2519857123.
    

    >> Share

    
    
31. HUANG KA, Nguyen HTV, Chen YY, Wu KJ, et al
    Broad neutralization of influenza B hemagglutinin antibodies via receptor mimicry and glycan engagement.
    Proc Natl Acad Sci U S A. 2026;123:e2532989123.
    

    >> Share

    
    

    
    Science

32. BOHM R, Schneider A, Betsch C, Lilleholt L, et al
    CDC communication undermines trust in vaccines.
    Science. 2026;392:475-477.
    

    >> Share

    
    

    
    Vaccine

33. TANG YS, Chen C, Lv H, Sun Y, et al
    Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.
    Vaccine. 2026;83:128634.
    

    >> Share

    
    
34. HUSSAIN M, Hassan M, Athar M, Khan S, et al
    Immunogenicity and safety of Sabin-strain inactivated poliovirus vaccine in infants: a systematic review and meta-analysis.
    Vaccine. 2026;83:128643.
    

    >> Share

    
    
35. WANG Y, Cui F, Lu QB
    Vaccination strategies for responding to public health emergencies of infectious diseases.
    Vaccine. 2026;83:128642.
    

    >> Share

    
    
36. BEOGO I, Muray M, Kibret TC, Xu Y, et al
    Between racism and rumors: understanding vaccine mistrust among older racially diverse adults in Canada.
    Vaccine. 2026;82:128611.
    

    >> Share

    
    
37. FISHER G, Wright B, Vickery T, Charania NA, et al
    Improving primary care vaccination rates in underserved and medically high-risk populations: A rapid review of strategies used in Australia and Aotearoa New Zealand.
    Vaccine. 2026;82:128624.
    

    >> Share

    
    
38. HERMET L, Soupey S, Descamps A, Coraci P, et al
    Association a school-based educational program and human papillomavirus (HPV) vaccination uptake in France: A pilot observational study.
    Vaccine. 2026;82:128639.
    

    >> Share

    
    
39. CHENG Z, Song Y, Liu M, Wu Y, et al
    Factors influencing vaccination staff willingness to vaccinate children with medical conditions: A cross-sectional study in China.
    Vaccine. 2026;82:128622.
    

    >> Share

    
    
40. LEWIS K, Goulbourne D, Weiser-Schlesinger A, Miller C, et al
    Motivating factors among LGBTQ+ individuals for the uptake of a forthcoming HIV vaccine: recommendations for enhancing preparedness.
    Vaccine. 2026;82:128597.
    

    >> Share

    
    
41. CONNER TL, Goguet E, Haines-Hull H, Segard A, et al
    mRNA COVID-19 vaccination induces minimal IgA in saliva in the absence of prior clinical or subclinical infection.
    Vaccine. 2026;82:128612.
    

    >> Share

    
    
42. DRISLANE S, Lake J, Attwell K
    Learning from government communication strategies to promote infant RSV immunisation: A cross-national study of France, Luxembourg, Spain, and Australia.
    Vaccine. 2026;79:128432.
    

    >> Share

    
    
43. JANSSEN RS, Coffman RL
    A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists.
    Vaccine. 2026;79:128437.
    

    >> Share

    
    
44. DE DIEU HARELIMANA J, Burger M, Zumwinkel M, Mohnani J, et al
    Hypoxia restricts the generation of BCG-responsive polycytotoxic T cells.
    Vaccine. 2026;79:128456.
    

    >> Share

    
    
45. HUNG HC, Jheng KW, Cheng HY, Hsieh HC, et al
    Intranasal prime-boost immunization with trivalent influenza virus neuraminidase proteins and conserved HCA2 sequences fused to a circularly permuted E. coli heat-labile enterotoxin B subunit.
    Vaccine. 2026;79:128488.
    

    >> Share

    
    
46. MENICAGLI D, Casigliani V, Panizza F, Gandolfi S, et al
    HPVoice: a single-blind three-arm RCT on social media communication strategies among adolescents in Tuscany, Italy.
    Vaccine. 2026;79:128466.
    

    >> Share

    
    
47. DE ROSA SC, Gravett RM, Hahn WO, Villaran M, et al
    DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.
    Vaccine. 2026;79:128487.
    

    >> Share

    
    
48. JAMISON AM, Saiyed S, Gardner LM
    MMR vaccine hesitancy in a polarized information ecosystem: Results from a cross-sectional survey of US adults.
    Vaccine. 2026;81:128568.
    

    >> Share

    
    
49. SAITOH A, Saitoh A, Kamiya H, Nakano T, et al
    Parental inquiry behavior and use of web-based information for childhood vaccination in Japan: Implications for communication quality and vaccination schedule adherence.
    Vaccine. 2026;82:128623.
    

    >> Share

    
    
50. ALI SA, Sultana S, Riaz A, Yousafzai MT, et al
    Effectiveness of monovalent rotavirus vaccine among young children in Pakistan: a test-negative case-control evaluation.
    Vaccine. 2026;81:128555.
    

    >> Share

    
    
51. LIU Y, Jia M, Mu X, Jiang B, et al
    Designing equitable influenza vaccination services for older adults in rural China: A discrete choice experiment.
    Vaccine. 2026;82:128590.
    

    >> Share

    
    

    
    Virus Res

52. LYU Y, Liu J, Qiao Y, Liu M, et al
    Development and Protective Evaluation of mRNA Vaccines Encoding the Glycoprotein Precursor of Lymphocytic Choriomeningitis Virus.
    Virus Res. 2026 Apr 26:199735. doi: 10.1016/j.virusres.2026.199735.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share